Synopsis:

Jubilant Pharmova’s wholly-owned subsidiary, Jubilant HollisterStier, launched a new $132 million Sterile Fill & Finish line in Spokane, boosting US CDMO capacity, driving revenue growth, and strengthening global market positioning. Can Jubilant Pharmova Outpace Global CDMO Competition?

The pharmaceutical contract manufacturing sector witnessed a notable uptick today, driven by a major capacity expansion by a leading North American CDMO. Jubilant Pharmova’s wholly-owned subsidiary, Jubilant HollisterStier, launched a new Sterile Fill & Finish line, boosting onshore capacity and strengthening its positioning among global peers. The expansion signals growing investor confidence amid robust demand from large innovator pharma companies and heightened focus on US-based manufacturing

See Full Page